Dean Allison - Member of Parliament - Members of Parliament - House of Commons of Canada Skip to main content Parliament of Canada Visit Parliament Visit Français FR Menu Share Email Facebook LinkedIn Twitter Parliamentary Business Parliamentary Business - Home The House Sitting Calendar House Publications Bills (LEGIS info ) Written Questions Petitions Votes Search the Debates (Hansard) Status of House Business Committees List of Committees and Overview Meetings Bills in Committee (LEGIS info ) Studies, Activities and Reports Search the Transcripts Participate Resources Procedural Information Library of Parliament Legislative Summaries Research Publications Parliamentary Historical Resources (1867-1993) Parliamentary Diplomacy Parliamentary Diplomacy - Home Speakers' Activities Parliamentary Associations Visits and Events Conferences Parliamentary Officers' Study Program Members Members - Home Members and Roles Members of Parliament The Speaker Ministry (Cabinet) Parliamentary Secretaries Party Leaders and other House Officers Related Information Party Standings Seating Plan Members' Expenditures Registry of Designated Travellers A Member's Typical Week Resources Contact Members of Parliament Constituencies Library of Parliament Historical Information (PARLINFO) Participate Participate - Home The House Attend Live Debates Watch and Listen to Chamber Proceedings Create or Sign a Petition A Typical Week at the House Contact a Member of Parliament Follow a Bill (LEGIS info ) Committees Attend Meetings Watch and Listen to Committee Proceedings Current Consultations How to Submit a Brief and Appear Layout of a Typical Committee Room Contact a Committee Resources Procedural Information Library of Parliament Classroom Activities Teacher Resources Teachers Institute About the House About the House - Home Transparency and accountability Board of Internal Economy By-Laws and Policies Members' Allowances and Services House Administration Reports and Disclosure Conflict of Interest Code for Members Accessibility Arts and Heritage History, Art and Architecture Future of the Parliamentary Precinct Memorial Chamber Carillon In pictures Virtual Tour of the House Live Hill Cam Photo Gallery Employment Employment - Home Working for the administration Current Opportunities at the House of Commons Eligibility and Selection General Application Who We Are and What We Offer Student Opportunities Student Employment Page Program Parliamentary Internship Programme Working for a Member of Parliament Current Listed Opportunities Working for a Member of Parliament Search Search Search Search Source Full website Member Bill Topic Petition Writen Question Share Email Facebook LinkedIn Twitter Parliamentary Business Parliamentary Business - Home The House Sitting Calendar House Publications Bills (LEGIS info ) Written Questions Petitions Votes Search the Debates (Hansard) Status of House Business Committees List of Committees and Overview Meetings Bills in Committee (LEGIS info ) Studies, Activities and Reports Search the Transcripts Participate Resources Procedural Information Library of Parliament Legislative Summaries Research Publications Parliamentary Historical Resources (1867-1993) Parliamentary Diplomacy Parliamentary Diplomacy - Home Speakers' Activities Parliamentary Associations Visits and Events Conferences Parliamentary Officers' Study Program Members Members - Home Members and Roles Members of Parliament The Speaker Ministry (Cabinet) Parliamentary Secretaries Party Leaders and other House Officers Related Information Party Standings Seating Plan Members' Expenditures Registry of Designated Travellers A Member's Typical Week Resources Contact Members of Parliament Constituencies Library of Parliament Historical Information (PARLINFO) Participate Participate - Home The House Attend Live Debates Watch and Listen to Chamber Proceedings Create or Sign a Petition A Typical Week at the House Contact a Member of Parliament Follow a Bill (LEGIS info ) Committees Attend Meetings Watch and Listen to Committee Proceedings Current Consultations How to Submit a Brief and Appear Layout of a Typical Committee Room Contact a Committee Resources Procedural Information Library of Parliament Classroom Activities Teacher Resources Teachers Institute About the House About the House - Home Transparency and accountability Board of Internal Economy By-Laws and Policies Members' Allowances and Services House Administration Reports and Disclosure Conflict of Interest Code for Members Accessibility Arts and Heritage History, Art and Architecture Future of the Parliamentary Precinct Memorial Chamber Carillon In pictures Virtual Tour of the House Live Hill Cam Photo Gallery Employment Employment - Home Working for the administration Current Opportunities at the House of Commons Eligibility and Selection General Application Who We Are and What We Offer Student Opportunities Student Employment Page Program Parliamentary Internship Programme Working for a Member of Parliament Current Listed Opportunities Working for a Member of Parliament Search Search Search Search Source Full website Member Bill Topic Petition Writen Question Start of content Members of Parliament Members of Parliament Key Roles Constituencies Election Candidates Results of the Monday, February 20, 2025, general elction will be official when the CHiref Electoral Officer has confirmed the name of the member of Parliament elected in each constituency. --!> Members of Parliament Dean Allison Dean Allison Overview Political Affiliation: Conservative Constituency: Niagara West Province / Territory: Ontario Preferred Language: English Expenditures Report For more information on the expenditures incurred by members in the discharge of their parliamentary functions, see the Summary of Expenditures for Members. Seat in the House See where Dean Allison sits in the House of Commons chamber. Roles Work Contact Current Roles Member of Parliament Niagara West, Ontario Committees Joint Chair BCAN Special Joint Committee on the Exercise of Powers Under the Building Canada Act SBCA Subcommittee on Agenda and Procedure of the Special Joint Committee on the Exercise of Powers Under the Building Canada Act Member BCAN Special Joint Committee on the Exercise of Powers Under the Building Canada Act SBCA Subcommittee on Agenda and Procedure of the Special Joint Committee on the Exercise of Powers Under the Building Canada Act Parliamentary Associations and Interparliamentary Groups Member of CEUS Canada-United States Inter-Parliamentary Group All Roles View all roles Dean Allison has held as a member of Parliament. Export as: XML CSV For more data options, please see Open Data Recent Work Explore Dean Allison's most recent work in the current session of Parliament. Chamber Interventions 42 in the current session Showing 5 of 42 Health Oral Question Period Thursday, June 11, 2026 Transcript (Hansard) Watch Cannabis Routine Proceedings Wednesday, June 3, 2026 Transcript (Hansard) Watch Religious Freedom Routine Proceedings Wednesday, June 3, 2026 Transcript (Hansard) Watch Committees of the House [Exercise of Powers Under the Building Canada Act] Routine Proceedings Wednesday, June 3, 2026 Transcript (Hansard) Watch Leader of the Liberal Party of Canada Statements by Members Wednesday, June 3, 2026 Transcript (Hansard) Watch × Loading ... Your browser does not support iframes. All Chamber interventions by Dean Allison Committee Interventions 65 in the current session Showing 5 of 65 BCAN Special Joint Committee on the Exercise of Powers Under the Building Canada Act Meeting no. 5 Tuesday, May 5, 2026 Transcript (Evidence) Meeting Minutes Meeting no. 4 Tuesday, April 28, 2026 Transcript (Evidence) Meeting Minutes Meeting no. 2 Tuesday, April 14, 2026 Transcript (Evidence) Meeting Minutes Meeting no. 1 Tuesday, March 10, 2026 Transcript (Evidence) Meeting Minutes ACVA Standing Committee on Veterans Affairs Meeting no. 30 Monday, April 20, 2026 Transcript (Evidence) Meeting Minutes All committee interventions by Dean Allison Bills None sponsored and 2 jointly seconded in the current session Sponsored Jointly Seconded None in the current session All bills sponsored by Dean Allison Dean Allison has indicated formal support by jointly seconding the following private members' bills sponsored by other members. Bill Number Title C-270 Stand on Guard Act C-262 An Act to amend the Canada Post Corporation Act Motions None in the current session Sponsored Jointly Seconded None in the current session All Private Members' motions sponsored by Dean Allison None in the current session Chamber Votes 172 in the current session Showing 5 of 172 Vote Number Subject Dean Allison Voted Vote Result Date No. 173 3rd reading and adoption of Bill C-30, An Act to implement certain provisions of the spring economic update tabled in Parliament on April 28, 2026 Nay Agreed To Thursday, June 18, 2026 No. 172 Government Business No. 13 (Proceedings on Bill C-22, An Act respecting lawful access) Nay Agreed To Wednesday, June 17, 2026 No. 171 Government Business No. 13 (Proceedings on Bill C-22, An Act respecting lawful access) (amendment) Yea Negatived Wednesday, June 17, 2026 No. 170 2nd reading of Bill C-267, An Act to establish a national framework to promote the durability of electronic products and essential home appliances Nay Agreed To Wednesday, June 17, 2026 No. 169 2nd reading of Bill C-26, An Act to authorize certain payments to be made out of the Consolidated Revenue Fund for the purpose of improving housing supply Nay Agreed To Wednesday, June 17, 2026 All votes by Dean Allison Written Questions 13 in the current session Showing 8 of 13 Question Number Date Asked Written Question Current Status Response Date Q-1363 Tuesday, June 16, 2026 With regard to SV40 promoter-enhancer fragments detected in certain COVID-19 vaccines: (a) what scientific evidence, studies, or data is Health Canada relying on to determine that any SV40 fragments present are inactive or non-functional; (b) when did Health Canada first become aware of the significant increase in reported deaths to the United States' Vaccine Adverse Event Reporting System in 2021 and 2022 compared to previous years; and (c) what actions, if any, did Health Canada take upon becoming aware of the increase in (b)? Awaiting response Monday, September 21, 2026 Q-1362 Tuesday, June 16, 2026 With regard to COVID-19 vaccines approved by Health Canada, including all initial approvals, amendments, expansions of indications, and subsequent authorizations (such as for booster doses or new age groups): (a) for each vaccine approved for COVID-19 (i) what was the vaccine name and manufacturer, (ii) what was the date the vaccine was approved, or the authorization was amended or expanded, (iii) what age groups did each approval or amendment apply to; and (b) for each approval or amendment in (a)(ii), (i) was it made under the Interim Order Respecting the Importation, Sale and Advertising of Drugs for Use in Relation to COVID-19, made by the Minister of Health on September 16, 2020, (ii) was it made in full compliance with section C.08.002(2) of the Food and Drug Regulations, C.R.C., c. 870 (the Regulations), including full compliance with paragraphs C.08.002(2)(g) and (h), (iii) was it was made as a designated COVID-19 drug (while that term was included in the Regulations), or as a public health emergency drug (as currently defined in the Regulations), (iv) was subsection C.08.002(2.1) applied, (v) was subsection C.08.002(2.2) applied, (vi) was subsection C.08.002(2.3) applied, (vii) was subsection C.08.002(2.4) applied, (viii) was subsection C.08.002(2.5) applied? Awaiting response Monday, September 21, 2026 Q-968 Thursday, March 19, 2026 With regard to the COVID-19 vaccine mandates for public service employees, contractors and temporary workers, announced in October 2021 and those for federally regulated companies announced in December 2021: (a) did the government classify this policy as a public-health measure under the Public Health Agency of Canada Act, a human-resources requirement under the Financial Administration Act or as an occupational safety preventive measure under Part II of the Canada Labour Code; (b) which ministers, deputy ministers and senior officials approved the final classification of the vaccination policy, and, for each, what was (i) their name, (ii) their title, (iii) the date of the approval; (c) what hazard-identification or residual-risk assessments were performed under Canada Occupational Health and Safety Regulations sections 10.4 to 10.6 to determine whether existing controls such as hand sanitization, barriers, masking, distancing and disinfection were inadequate before escalation to mandating the COVID-19 vaccine; (d) were Policy and Workplace Health and Safety Committees consulted under Canada Occupational Health and Safety Regulations section 10.8 and section 125(1)(z.14) of the Code prior to implementation of the COVID-19 vaccine mandate, and, if so, for each meeting, what are the details, including the (i) date, (ii) list of attendees, (iii) outcome of the meeting, (iv) internal tracking or file number of the minutes; (e) did any federal department submit a notice or obtain approval under Canada Occupational Health and Safety Regulations section 12.04(1) when introducing the COVID-19 vaccine mandate as a biological preventive measure, and what documentation demonstrates compliance with 12.04(3) that the measure itself “did not create or contribute to a hazard”; (f) did Department of Justice Canada, Employment and Social Development Canada, Health Canada or the Treasury Board Secretariat issue any legal opinions or interpretive memos clarifying whether COVID-19 vaccination constituted “personal protective equipment” or was otherwise subject to Part II of the Canada Labour Code, and, if so, for each opinion or memo (i) what was the date, (ii) what was the name of the issuer, (iii) who received the information, (iv) on what date was it tabled in the House of Commons; (g) did Employment and Social Development Canada Occupational Health and Safety Officers revise 2020 findings that the existing hierarchy of control measures under section 122.2 of the Canada Labour Code were adequate, and, if so, for each revision what was the (i) date of the revision, (ii) reason for revision, (iii) evidence to justify the revision; (h) did the Minister of Labour determine that COVID-19 vaccination qualified for introduction at the third stage of the hierarchy, in section 122.2 of the Canada Labour Code requiring hazard elimination or reduction before resorting to personal protective equipment, and, if so, what analysis supported that decision; (i) following the Prime Minister’s 2021 announcement that the COVID-19 vaccine policy aimed to “protect the safety of our workplaces,” did the government classify the COVID-19 vaccine mandate measure as falling within its Part II duties to protect employees at work, and how was that classification conveyed to departments; (j) were employees explicitly informed that the COVID-19 vaccine mandate was implemented to protect workplace health and safety and therefore that their rights under sections 125 to 128, including the right to know, participate and refuse dangerous work, would apply, and, if not, why not; (k) which departments maintain records of federal employee exposures or adverse reactions resulting from the mandatory COVID-19 vaccine mandate policy pursuant to section 125(1)(j), how many reports were made and what is the schedule for retention and reporting; (l) which departments participated in interdepartmental meetings to coordinate the workplace COVID-19 vaccination policy, and which department led the decision to classify it as a public-health or human-resources measure rather than occupational protective equipment; (m) does the government plan to propose amendments to Part II of the Canada Labour Code or to the Canadian Occupational Health and Safety Regulations to clarify the classification of biological or pharmacological interventions in workplace safety programs; (n) did the Minister of Labour consult the National Advisory Committee on Occupational Safety and Health with respect to sections 122.2 and 124 of the Canada Labour Code regarding compliance before introducing medical or biological measures as occupational controls; (o) did the Minister of Health, Health Canada or the Public Health Agency of Canada have knowledge that biochemical components of the COVID-19 vaccines were registered chemicals, and, if so, on what date did they inform all federal employees of these chemicals under section 125.1 of the Canada Labour Code; and (p) was the mandatory vaccination policy for federal workers classified as a workplace safety measure under Part 2 of the Canada Labour Code, and, if so, on what dates were employees informed to document and report all adverse events, related to vaccination to the provincial worker's compensation boards for review? Answered Wednesday, May 6, 2026 Q-849 Monday, February 9, 2026 With regard to the Public Health Agency of Canada’s “Cases Following Vaccination” reports published from August 2021 to September 2022: (a) why did the Public Health Agency of Canada decide to begin calculating and comparing COVID-19 deaths using vaccination status, on the date of COVID-19 vaccine approval in December 2020, rather than the date on which each corresponding dose level actually began to be administered, or using weekly death counts, as is done for Statistics Canada’s Deaths by Age and Deaths by cause statistics; (b) what internal documentation, analyses, and external scientific or technical references were consulted to inform the methodological choice described in (a); (c) within the Public Health Agency of Canada, which organizational units and officials or governing authorities (i) proposed the methodology described in (a), (ii) reviewed it (including any internal methodological or ethics review), (iii) formally approved it for use in the “Cases Following Vaccination” reports; (d) in what way does the methodology described in (a) permit the observation and analysis of time-based (for example, weekly or seasonal) variations in COVID-19 deaths by vaccination status in relation to contemporaneous factors, including, but not limited to, seasonal changes and the dates on which additional vaccine doses (for example, second, third, or booster doses) began to be administered; and (e) in developing and approving this methodology, did the Public Health Agency of Canada rely on, or explicitly reference, any guidance, standards, or methodologies issued by the World Health Organization or any other international public health body, and, if so, which specific documents or authorities were relied upon? Answered Monday, April 13, 2026 Q-848 Monday, February 9, 2026 With regard to Health Canada, Public Health Agency of Canada and National Advisory Committee on Immunization expenditures between 2020 and 2023: (a) which projects and departments researched the safety of the COVID-19 vaccines and how much did each project cost, broken down by (i) project name, (ii) department name, (iii) start date, (iv) completion date, (v) cost; (b) which projects and departments researched manufacturers' COVID-19 vaccine applications and how much did each project cost, broken down by (i) vaccine name, (ii) project name, (iii) department name, (iv) start date, (v) completion date, (vi) cost; (c) which projects and departments informed Canadians and specialists about the adverse events associated with the COVID-19 vaccines, broken down by (i) project name, (ii) department name, (iii) adverse event, (iv) start date, (v) completion date, (vi) date Canadians were informed about the adverse event, (vii) cost; and (d) which projects and departments researched vaccine hesitancy and how much did each project cost, broken down by